843 related articles for article (PubMed ID: 14971932)
1. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Sep; 37(37):12700-6. PubMed ID: 9737846
[TBL] [Abstract][Full Text] [Related]
3. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
Brown AM; Lemkul JA; Schaum N; Bevan DR
Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
[TBL] [Abstract][Full Text] [Related]
4. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
Misiti F; Clementi ME; Giardina B
Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics study to investigate the effect of chemical substitutions of methionine 35 on the secondary structure of the amyloid beta (Abeta(1-42)) monomer in aqueous solution.
Triguero L; Singh R; Prabhakar R
J Phys Chem B; 2008 Feb; 112(7):2159-67. PubMed ID: 18220385
[TBL] [Abstract][Full Text] [Related]
8. Comparative molecular dynamics studies of wild-type and oxidized forms of full-length Alzheimer amyloid beta-peptides Abeta(1-40) and Abeta(1-42).
Triguero L; Singh R; Prabhakar R
J Phys Chem B; 2008 Jun; 112(23):7123-31. PubMed ID: 18476733
[TBL] [Abstract][Full Text] [Related]
9. Role of methionine 35 in the intracellular Ca2+ homeostasis dysregulation and Ca2+-dependent apoptosis induced by amyloid beta-peptide in human neuroblastoma IMR32 cells.
Piacentini R; Ripoli C; Leone L; Misiti F; Clementi ME; D'Ascenzo M; Giardina B; Azzena GB; Grassi C
J Neurochem; 2008 Nov; 107(4):1070-82. PubMed ID: 18990116
[TBL] [Abstract][Full Text] [Related]
10. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S; Reif B
Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
[TBL] [Abstract][Full Text] [Related]
11. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.
Sharpe S; Yau WM; Tycko R
Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307
[TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of the beta-amyloid peptide fragment, beta(12-28).
Jayawickrama D; Zink S; Vander Velde D; Effiong RI; Larive CK
J Biomol Struct Dyn; 1995 Oct; 13(2):229-44. PubMed ID: 8579784
[TBL] [Abstract][Full Text] [Related]
14. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
[TBL] [Abstract][Full Text] [Related]
15. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell.
Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F
Int J Biochem Cell Biol; 2004 Oct; 36(10):2066-76. PubMed ID: 15203119
[TBL] [Abstract][Full Text] [Related]
16. 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length.
Danielsson J; Andersson A; Jarvet J; Gräslund A
Magn Reson Chem; 2006 Jul; 44 Spec No():S114-21. PubMed ID: 16826550
[TBL] [Abstract][Full Text] [Related]
17. The Alzheimer beta-peptide shows temperature-dependent transitions between left-handed 3-helix, beta-strand and random coil secondary structures.
Danielsson J; Jarvet J; Damberg P; Gräslund A
FEBS J; 2005 Aug; 272(15):3938-49. PubMed ID: 16045764
[TBL] [Abstract][Full Text] [Related]
18. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
[TBL] [Abstract][Full Text] [Related]
19. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
Ikebe J; Kamiya N; Ito J; Shindo H; Higo J
Protein Sci; 2007 Aug; 16(8):1596-608. PubMed ID: 17656579
[TBL] [Abstract][Full Text] [Related]
20. Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid.
Nakamura M; Shishido N; Nunomura A; Smith MA; Perry G; Akutsu H; Hayashi T
Free Radic Res; 2010 Jul; 44(7):734-41. PubMed ID: 20370566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
